Portfolio

1. Rugo HS, Bardia A, Gradishar WJ, et al. Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists. Breast 2025;82:104485. DOI: 10.1016/j.breast.2025.104485.
2. Page-Wilson G, Oak B, Silber A, et al. Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures. Pituitary 2023;26(4):364-374. DOI: 10.1007/s11102-023-01314-7.
3. Tam C, Pinilla-Ibarz J, Castillo CG, et al. Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL. Blood Adv 2023;7(22):6819-6828. DOI: 10.1182/bloodadvances.2023010879.
4. Kapural L, Jameson J, Johnson C, et al. Treatment of nonsurgical refractory back pain with high-frequency spinal cord stimulation at 10 kHz: 12-month results of a pragmatic, multicenter, randomized controlled trial. J Neurosurg Spine 2022;37(2):188-199. DOI: 10.3171/2021.12.SPINE211301.
5. Awan FT, Addison D, Alfraih F, et al. International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL. Blood Adv 2022;6(18):5516-5525. DOI: 10.1182/bloodadvances.2022007938.
6. Gupta M, Scowcroft J, Kloster D, et al. 10-kHz Spinal Cord Stimulation for Chronic Postsurgical Pain: Results From a 12-Month Prospective, Multicenter Study. Pain Pract 2020;20(8):908-918. DOI: 10.1111/papr.12929.